Genomics analysis using next-generation sequencing (NGS) technology is fundamental to successful high-throughput testing of a broad range of samples. NGS is particularly impactful for rare disease research, where a better understanding of the underlying genomics has the potential to significantly improve screening, monitoring, and treatment for some of the most understudied disorders.
Download this article to learn how a woman and children’s hospital in Paris uses automated NGS solutions to advance their exploration of chronic and acute rare diseases.
